45 Stocks Moving In Wednesday's Mid-Day Session

Gainers

• Bio-Path Holdings Inc BPTH shares climbed 81.6 percent to $8.38 after the company's Phase 2 trial of BP1001 for the treatment of acute myeloid leukemia demonstrated 'meaningful clinical improvement' with an 'excellent' patient safety profile.
• Aytu Bioscience Inc AYTU climbed 43.6 percent to $1.58 after the company announced an agreement with SUDA Pharmaceuticals to distribute ZolpiMist outside of the US and Canada.
• AeroVironment, Inc. AVAV gained 21.2 percent to 93.04 on better-than-expected third-quarter earnings.
• Abercrombie & Fitch Co. ANF rose 19.2 percent to $25.44 following upbeat Q4 results.
• Four Seasons Education (Cayman) Inc. FEDU gained 15 percent to $2.46.
• The Stars Group Inc. TSG climbed 14.5 percent to $17.99 after reporting Q4 results. The company also provided FY19 EPS guidance of $1.87-$2.11 and sales guidance of $2.64 billion-$2.77 billion.
• J.Jill, Inc. JILL rose 12.6 percent to $6.62 after the company reported better-than-expected Q4 EPS and declared a special dividend of $1.15 per share.
• DPW Holdings Inc DPW shares gained 11.4 percent to $0.089 after the company announced it has reduced total debt by $3 million in 2019 so far.
• China Automotive Systems, Inc. CAAS rose 8.7 percent to $4.37 after the company reported that it has won major exclusive supply contract from China's Great Wall Motor Co.
• PlayAGS, Inc. AGS climbed 8.5 percent to $26.30 after the company reported better-than-expected Q4 sales results.
• ERYTECH Pharma S.A. ERYP gained 7.8 percent to $9.70. ERYTECH Pharma is expected to report Q4 results on March 12.
• Fuwei Films (Holdings) Co., Ltd. FFHL climbed 7.7 percent to $2.53.
• Ambarella, Inc. AMBA rose 7 percent to $43.36 after reporting a fourth-quarter earnings beat.
• Zayo Group Holdings Inc ZAYO climbed 6.6 percent to $26.02 after the company's board announced it is evaluating strategic alternatives.
• Seaspan Corporation SSW rose 5.6 percent to $9.23 following Q4 results.
• Infinity Pharmaceuticals Inc. INFI gained 5.5 percent to $1.73 after the company announced an agreement for the right to receive royalty payments on sales of COPIKTRA, payable by Verastem.
• LyondellBasell Industries NV LYB gained 5.3 percent to $88.59 after Goldman Sachs upgraded the company's stock from Neutral to Buy.
• Aon plc AON rose 4.8 percent to $164.73 after the company issued a press release indicating it is not pursuing business combination with Willis Towers Watson. On Tuesday, the company said it was in the early stages of considering a merger.

Check out these big penny stock gainers and losers

Losers

• Valeritas Holdings Inc VLRX shares dipped 24.2 percent to $0.4165 after the company reported mixed Q4 earnings and issued Q1 sales guidance below consensus estimates.
• Qutoutiao Inc. QTT fell 17.5 percent to $12.91 after the company reported a wider net loss compared to Q4 last year.
• The9 Limited NCTY dropped 16.1 percent to $1.8885.
• Nio Inc - ADR NIO shares fell 14.7 percent to $8.67 following Q4 results. Although the company beat sales estimates, it terminated its plan for a Shanghai manufacturing plant and said it expects a greater-than-anticipated sequential decrease in deliveries.
• InnerWorkings, Inc. INWK shares dropped 14.6 percent to $4.23 after the company reported Q4 results, and announced extension and expansion of partnership with Beam Suntory.
• Cool Holdings, Inc. AWSM fell 14.6 percent to $3.44 after climbing 24.96 percent on Tuesday.
• Fuling Global Inc. FORK shares declined 12.3 percent to $2.35.
• The Meet Group, Inc. MEET fell 11.7 percent to $5.24 after the company reported Q4 results.
• DBV Technologies S.A. DBVT shares fell 11.4 percent to $8.30 after reporting full-year 2018 results.
• Endologix, Inc. ELGX dropped 11.1 percent to $5.87. Endologix said the ratio of its previously-announced reverse stock split of its outstanding shares has been fixed at 1-for-10. Beginning with the opening of trading March 6, the shares will trade on the NASDAQ on a reverse stock split-adjusted basis.
• BIQI International Holding Corporation BIQI dipped 10.7 percent to $2.09.
• Ligand Pharmaceuticals Incorporated LGND shares fell 9.9 percent to $108.72 after reporting the sale of Promacta assets and royalty for $827 million.
• INSYS Therapeutics, Inc. INSY shares dropped 9.8 percent to $5.46.
• Chico's FAS, Inc. CHS fell 9.6 percent to $5.46 after the company reported comparable sales were down 3.5 percent in Q4.
• Sarepta Therapeutics, Inc. SRPT fell 9.3 percent to $134.92. Sarepta priced its 2.6 million share offering at $144 per share.
• Cardlytics Inc CDLX fell 9.1 percent to $16.75 despite reporting a fourth-quarter earnings beat. The company issued weak first-quarter sales guidance.
• Veeco Instruments Inc. VECO dropped 8.7 percent to $11.09 after Stifel Nicolaus downgraded the company's stock from Buy to Hold and announced a price target of $12 per share.
• Capital Senior Living Corporation CSU shares declined 8.6 percent to $4.14.
• Renewable Energy Group Inc REGI fell 8.5 percent to $24.50 after the company reported lower-than-expected Q4 sales.
• Vivint Solar, Inc. VSLR dropped 8.4 percent to $4.8250 after the company reported worse-than-expected Q4 EPS and sales results.
• JinkoSolar Holding Co., Ltd. JKS fell 7.9 percent to $16.91.
• Materialise NV MTLS shares declined 7.5 percent to $17.05 following downbeat quarterly earnings.
• United Natural Foods Inc UNFI fell 7.1 percent to $13.95. United Natural Foods reported better-than-expected Q2 earnings and issued strong full-year forecast.
• Kandi Technologies Group, Inc. KNDI fell 6.7 percent to $7.36.
• Willis Towers Watson Public Limited Company WLTW fell 6.2 percent to $170.81 following Aon's decision to no longer pursue a merger with the company.
• Alnylam Pharmaceuticals, Inc. ALNY fell 5.5 percent to $83.42 after the company announced that four of its secondary endpoints did not meet the hierarchical threshold for significance in a Phase 3 study of givosiran; many patients also reported serious adverse events.
• General Electric Company GE dropped 5 percent to $9.41 after company on Tuesday said it expects to face headwinds for a couple of years and will see even greater negative free cash flow this year.